Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS5906579 A
Publication typeGrant
Application numberUS 08/907,824
Publication dateMay 25, 1999
Filing dateAug 14, 1997
Priority dateAug 16, 1996
Fee statusPaid
Also published asUS5904147, WO1998006450A1
Publication number08907824, 907824, US 5906579 A, US 5906579A, US-A-5906579, US5906579 A, US5906579A
InventorsThomas J. Vander Salm, A. Alan Conlan, Yuri E. Kazakevich, Steven W. Ek, Gheorghe Mihalca
Original AssigneeSmith & Nephew Endoscopy, Inc., University Of Massachusetts
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Through-wall catheter steering and positioning
US 5906579 A
Abstract
A method of positioning a catheter, for example a balloon or treatment catheter. The catheter is inserted in a passage and sensed through the luminal wall to correctly determine its position. As applied to prevent hemorrhage during surgery the method involves inserting the catheter in a deflated configuration along a passage such as a blood vessel near to the operative site in a position determined by direct or video-assisted sensing from outside the passage. In the event a blood vessel is cut during surgery, the already-positioned catheter inflates a balloon to occlude the passage and stop blood flow into the injured site. In one aspect, a flow-directed catheter includes an inflatable balloon attached at its distal end and an optical fiber connected to one or more light emitting regions positioned at the tip or in the vicinity of the balloon. The light is divergent and is emitted at one or more points to provide beacons that are readily detected through the walls of a blood vessel and permit a direct determination of the exact location of the balloon within the vessel. Rather than a flow-directed balloon catheter, a drug-delivery or other catheter may be used. In that case the light emitting regions are located at or adjacent to one or more drug delivery ports or other active areas in the catheter. In another or further aspect, one or more magnetic elements are provided on the catheter, and an external magnet is used to feel and engage the catheter through the vessel wall, sense its position, steer and move it along branching vessels, and anchor the balloon in a desired position.
Images(5)
Previous page
Next page
Claims(23)
What is claimed is:
1. A method for controlling hemorrhage at a desired position in a vessel in an enclosed surgical arena, said method comprising the successive steps of
providing a flexible catheter body configured for travel within said vessel and including an elongated tubular wall having a proximal end and a distal end, and having at least an inflation lumen and an optical fiber extending between said ends, said fiber being configured for coupling to receive light at the proximal end and guide it to the distal end, and said fiber being configured at said distal end as a beacon which emits said received light through a wall of the vessel as a precise position marker visible externally of a wall of the vessel for allowing positioning of said catheter distal end in the vessel, said catheter body further having an inflatable balloon secured to its distal end, said balloon being inflatable via said inflation lumen and being configured for travel with said flexible catheter along a blood vessel extending to said surgical arena, said inflation lumen having a distal opening to said inflatable balloon for providing a fluid for rapid inflation and deflation of said balloon,
inserting said catheter body along the vessel,
navigating said catheter body through said vessel by directly sensing the light emitted by said beacon externally of the vessel to determine a location where an inflation of said balloon occludes blood flow to said surgical arena, and
inflating said balloon to occlude blood flow to said surgical arena, thereby controlling said hemorrhage.
2. The method of claim 1, wherein the step of inserting includes inserting the catheter into said vessel and allowing said balloon to be carried, by pressure of blood flow exerted on the balloon, toward the surgical arena.
3. The method of claim 2, wherein the step of inserting includes introducing the catheter by cutdown or percutaneous insertion into a vein and advancing the balloon to a position in a blood vessel at a site selected from a lung, liver or abdomen site.
4. The method of claim 1, wherein the surgical arena is a video-assisted surgical arena accessed in a closed body region and wherein the step of navigating includes viewing a video image of light emitted through the walls of blood vessel within the body.
5. The method of claim 4, wherein the enclosed surgical arena is a body cavity selected from among the pleural, peritoneal and pericardial cavity, and operating spaces formed in the preplural, preperitoneal and prepericardial areas of a body.
6. The method of claim 1, wherein the balloon is shaped to occlude a pulmonary artery.
7. The method of claim 1, including the step of providing an inflation medium to the balloon to occlude flow through the vessel at said position.
8. The method of claim 1, wherein said beacon emits light substantially omnidirectionally from a localized site on the catheter.
9. The method of claim 8, wherein the catheter is a drug delivery catheter and said localized site is associated with a drug delivery port so that viewing the light emission determines a location for drug delivery.
10. The method of claim 1, further comprising the steps of:
creating incisions in a body and inserting surgical instruments and endoscopic camera through said incisions to perform surgery at an operative site,
inserting the balloon catheter, wherein the catheter is provided with said beacon located at a defined position, through a vessel to a neighborhood of the operative site, and
establishing visual contact with the beacon through a vessel wall to thereby determine a position of the balloon catheter effective to block circulation to the surgical arena.
11. A method for controlling hemorrhage at a position in a vessel in an enclosed surgical arena said method comprising the successive steps of
providing a flexible catheter having an inflatable balloon,
securing to said balloon magnetic material for magnetic engagement and positioning of the balloon by manipulation of a magnet located outside the vessel,
inserting said catheter along the vessel to a location where an inflation of said balloon occludes blood flow to said surgical arena, and
inflating said balloon to occlude blood flow to said surgical arena to control the hemorrhage.
12. The method of claim 11, wherein the step of inserting said catheter body includes at least one of
moving said catheter by magnetically engaging the magnetic material, and
anchoring said catheter by magnetically engaging the magnetic material.
13. The method of claim 11, further comprising the successive steps of
creating incisions in a body and inserting surgical instruments and an endoscopic camera through said incisions to perform surgery at an operative site,
inserting the balloon catheter, wherein the catheter is provided with said magnetic material located at a defined position, through a vessel to a neighborhood of the operative site, and
establishing magnetic contact with the marker through a vessel wall to thereby determine a position of the balloon catheter effective to block circulation to the surgical arena.
14. The method of claim 13, wherein said surgical arena is selected from the group including thoracoscopic, laparoscopic, endoluminal, perivisceral and intra-articular surgical arenas.
15. The method of claim 11, wherein the step of inserting includes inserting the catheter into a vessel and allowing said balloon to be carried by pressure of blood flow exerted on the balloon, toward the surgical arena.
16. The method of claim 15, wherein the step of inserting includes introducing the catheter by cutdown or percutaneous insertion into a vein and advancing the balloon to a position in a blood vessel at a site selected from a lung, liver or abdomen site.
17. The method of claim 11, wherein the balloon is shaped to occlude a pulmonary artery.
18. The method of claim 11, including the step of providing an inflation medium to the balloon to occlude flow through the vessel at said position.
19. A method for controlling hemorrhage in an enclosed surgical arena, such method comprising the steps of
inserting into a vessel extending to said surgical arena a balloon catheter,
providing a directly sensible marker, selected from the group consisting of a magnetically engageable marker and a light emitting marker, on said catheter,
directly sensing the marker carried by the catheter from outside the vessel, and
positioning the balloon to a location where an inflation of said balloon occludes blood flow to a surgical arena, and inflating said balloon to occlude blood flow to the surgical arena.
20. The method of claim 19, wherein said marker is a magnetically engageable marker, and further comprising the step of magnetically feeling the catheter through the vessel wall by engaging said marker.
21. The method of claim 19, wherein said balloon has magnetic material thereon and said marker is a light emitter which is directly viewed through a vessel wall, and further comprising the steps of magnetically manipulating the catheter through the vessel wall by engaging said magnetic material while viewing the marker, and magnetically anchoring the catheter in a desired position.
22. The method of claim 21, wherein the step of magnetically anchoring includes anchoring in a pulmonary artery to occlude circulation to a pulmonary lobe.
23. The method of claim 22, further comprising the step of defunctioning the lobe to shrink the lobe for surgery.
Description
RELATED APPLICATIONS

This application is continuation-in-part application of co-pending U.S. patent application Ser. No. 08/696,572, filed Aug. 16, 1996. That application is expressly incorporated herein by reference.

BACKGROUND OF THE INVENTION

This invention relates to intravascular catheters, and more particularly to balloon-tipped catheters and to novel catheters and methods of using such catheters during surgery.

Minimally invasive or video-assisted surgical procedures are being rapidly developed as a method of replacing conventional surgery. These new techniques may reduce trauma and result in fewer surgically-induced complications and lower medical costs associated with hospital stays. Current minimally invasive surgical techniques include laparoscopic, endoluminal, perivisceral, endoscopic, thoracoscopic, intra-articular and hybrid approaches. As an illustration of this procedure, access into a body cavity, e.g., peritoneal or pleural cavity, is made through a small incision. The cavity may be insufflated with fluid, such as carbon dioxide or saline fluid, to provide a working space, if necessary, as is commonly done for laparoscopic or intra-articular procedures. Generally, the gas or fluid is injected through an insufflation needle. After removing the needle, surgical instruments may be inserted at the incision into the cavity or working space, and an endoscopic camera is inserted through the opening into the cavity. Under direct visualization, additional incisions are then made at strategic locations in the body for inserting secondary surgical instruments to perform the operation.

Despite the significant advances in minimally invasive techniques, serious complications may arise due to accidental cutting or perforation of a vessel or organ. As an illustration, the application of these techniques to pulmonary resections, particularly lobectomy or partial lobectomy, has been limited by the fear that the pulmonary artery is relatively inaccessible, so that hemorrhage, if it occurs, cannot be easily stopped in a closed chest. Currently, the routinely used method of controlling hemorrhage in a closed space is to apply a clip or staple to the injured vessel. This would be a difficult undertaking once hemorrhage commences due to the lack of visibility at the operative site in a closed cavity.

Therefore, a need exists for an effective manner of stopping vascular flow into an operative site during a minimally invasive surgical procedure, particularly in thoracoscopic applications.

The use of balloon-tipped catheters which are flow-directed to the pulmonary artery for measuring right-sided vascular pressures was first described in 1953 (Lategola, M. and Rahn, H. (1953) Proc. Soc. Exp. Biol. Med. 84: 667-68). Since then, pulmonary artery balloon catheters have been widely used for monitoring vascular pressures in the fields of anesthesia and critical care medicine. In 1970, Swan, Ganz and associates reported the use of a flow-directed catheter in humans and further refined it for direct measurement of pulmonary capillary wedge pressure (Swan et al. (1970) N Engl J Med 283: 447-51). At present, this catheter is an invaluable aid in the management of critically ill patients with pulmonary and cardiac disease. Moreover, pulmonary wedge pressure (as an estimation of left ventricular filling pressure or preload) is the standard of reference for intravascular volume management.

In addition to monitoring right heart pressures, balloon-tipped catheters, particularly flow-directed Swan-Ganz catheters have been routinely used for sampling mixed venous blood, and for infusing solutions. Numerous variations of these catheters are available in configurations containing double and triple lumens, as described in U.S. Pat. Nos. 3,746,003, 3,833,004, 3,710,781, 3,634,924, 3,152,592, 3,044,468, 3,050,066 and 2,845,930 and elsewhere.

Balloon-tipped catheters are generally inserted using pressure waveform monitoring, with or without fluoroscopic control. Typically, the catheter may be inserted into a patient at the bedside into a median basilic or deep brachial vein by a cutdown, or it may be inserted percutaneously through the subclavian, internal jugular or femoral vein. After insertion, the balloon on the catheter tip is carried by the stream of maximal blood flow through the right atrium and right ventricle into the branch of the right pulmonary artery and, with a lesser frequency, into the left pulmonary artery. Variations on the ultimate location of the catheter depend mainly on the position of the patient when the catheter is inserted (Parlow, J. L. (1992), J. Cardiothoracic and Vascular Anesthesia 6 (1):20-23), but surgeons also develop their own movements for steering to a desired site.

A primary objective of the present invention is to provide a modified balloon-tipped flow-directed catheter useful for stopping the blood flow in the event of injury to a vessel during minimally invasive surgery.

If such a catheter could be dependably and quickly deployed in a determined position by a vessel branch point, it could be used intraoperatively to provide emergency hemostasis.

It is thus an object of the invention to provide a balloon catheter that is readily deployed during endoscopic surgery at a site effective to occlude a vessel supplying the site of surgery.

It is a further object to provide a method of quickly and efficiently deploying such balloon, and method of stopping hemorrhage with the balloon.

It is also an object of the invention to provide a balloon-tipped catheter containing a light fiber positioned in the balloon assembly which emits light in the vicinity of the balloon.

Another object is to provide a method of controlling hemorrhage during minimally invasive surgery, such as thoracic surgery, wherein the balloon catheter of the present invention is inserted into the pulmonary artery on the side of the lung to be operated on and the exact location of the balloon is determined by direct visual or video observation of emitted light. In the event of injury to the vessel during surgery, the balloon is inflated to stop the blood flow.

It is more generally an object of the invention to provide an endovascular catheter and a method of steering, positioning and anchoring the catheter during surgery.

SUMMARY OF INVENTION

The application of a minimally invasive surgical procedure to thoracic operations, particularly pulmonary resections, has been limited by fear of major hemorrhage, in the closed chest, of the pulmonary artery or vessels fed by it. Current methods of stopping hemorrhage would be greatly complicated by the lack of visibility at a closed operative site that results from uncontrolled vascular inflow to the artery. The present invention involves a method especially useful in thorascopic surgery and a catheter for practicing the method, which in a preferred embodiment is a balloon catheter operable for controlling hemorrhaging during surgery by precisely positioning the balloon at a point in a blood vessel which is effective to occlude blood flow to the surgical site. In one of its broadest aspects, the method involves trans-viewing a beacon on a catheter positioned inside of tissue near the operative arena. In another of its broadest aspects, the method involves controlling the balloon or catheter tip by providing a positioning magnet at the tip, and magnetically engaging the magnet from outside the vessel.

In one aspect the catheter of the present invention is preferably a flow-directed catheter having an inflatable balloon located at its distal tip, and an inflation lumen for conducting fluid through the catheter for rapid inflation or deflation of the balloon. A light fiber extends through the catheter body to emit a beacon of light at a region positioned in the vicinity of the balloon. The light is relatively bright, and the emitted light is viewed from the surgical cavity, looking directly through the wall of the blood vessel to allow the position of the balloon in the vessel to be directly and quickly determined, thus simplifying and expediting balloon deployment in vivo.

In a preferred embodiment, the optical fiber is mounted in one lumen of a multi-lumen catheter, and receives light emanating from a light source which is coupled to an optical port located at the proximal end of the catheter. The fiber carries the light to one or more light emitting regions in the vicinity of the balloon. The locations of the light emitting regions are chosen like the running lights of a vehicle, to directly indicate the limits or extent of the balloon. Such sites, for example, may include small bands or points at the proximal and distal ends of the balloon, may include regions that extend for the entire length of the balloon, or may include a combination of such positions. One light emitting region may be formed at the end of an optical fiber by simply fusing the end to melt it back into a clear luminescent sphere, a point-like termination approximately one millimeter in diameter which allows substantially all of the input light to escape omnidirectionally. The emitted light is of a brightness to be readily viewed through the corresponding blood vessel wall, but may be spectrally filtered, for example to be IR-free, to avoid excessive heating of the catheter, fiber or adjacent tissue while nonetheless having sufficient power to be readily seen. Alternatively, the emitted light may be of a wavelength that is not directly visible, but which is within the range of the endoscopic video camera and is clearly visible only in the video image. In this case, the wavelength may be selected to have a high tissue-penetrating range, allowing the emitters to be operated at a lower power level without sacrificing visibility. Thus, the endoscopic visual image is formed to include not only the surface tissue of the surgical arena, but one or more bright spots from the light emitters which lie in a vessel below the surface.

The catheter of the present invention preferably contains at least two lumens; namely, an inflation lumen for conducting fluid therethrough for rapid inflation or deflation of the balloon, and a lumen which carries the fiber. Additional lumens may be and preferably are supplied to fulfill other useful delivery or monitoring tasks. Such additional lumens may include a monitor lumen, extending through the catheter body distally past the balloon, which is used for carrying liquids to and from the proximal and distal ends of the catheter, as well as a proximal injectate lumen, which terminates at the proximal end of the balloon to supply heparin or other injectate to an outlet in that position. In general, only one or two such additional lumens may be supplied, due to the overall constraints on the size and stiffness of the catheter necessary to permit endovascular insertion.

As noted above, a thin optical fiber mounted in one lumen carries light from a light or source input located at the proximal end of the catheter to the light emitting region(s) in the vicinity of the balloon. In one configuration, the monitor lumen communicates with blood at the pulmonary arterial pressure when the catheter is in place and the balloon is deflated, or measures pulmonary capillary wedge pressure when the balloon is inflated. In another configuration, the monitor lumen is adapted at its proximal end for at least one of blood sampling or infusion of a therapeutic drug. As with the basic protocol described above for the first embodiment, by illuminating the light emitting region, the balloon is visually positioned in vivo.

In yet another embodiment, the light emitting balloon has at least one portion which inflates to a size and shape capable of occluding a blood vessel, and includes an anchor for immobilizing the balloon in the vessel before it is fully inflated. The anchor may be effected by a second portion of the balloon assembly which inflates to a shape or size that contacts the vessel, and without fully obstructing circulation, prevents movement of the balloon in a vessel.

In another aspect, the invention includes a method of preventing or controlling hemorrhage during minimally invasive thoracoscopic surgery by positioning a balloon to obstruct vascular inflow to the pulmonary artery or a branch thereof. According to this aspect, one or more incisions are made and an endoscope is inserted to view the surgical arena. The catheter of the present invention with its balloon deflated is inserted by cutdown or percutaneous insertion into a vein. The balloon is unfurled or partially inflated, and flow-directed through the heart and into the pulmonary artery on the side of the lung which is to be operated on. Prior to surgery, the catheter is then moved to the exact location of a relevant branch vessel by illuminating the fiber and observing the artery to see light emitted in the vicinity of the balloon. This "trans-viewing," or observation through the vessel tissue of the internal catheter beacon allows the exact location to be seen on the endoscope display screen. Surgery then proceeds, and in the event of accidental cutting of the pulmonary artery or of a secondary blood vessel during surgery, the already-positioned balloon is rapidly inflated to occlude the relevant supply vessel, thus stopping blood flow and making it possible to proceed with surgical closure of the bleed. The method disclosed herein is preferably applied to pulmonary resections including, but not limited to, lobectomy, bilobectomy and pneumonectomy.

Furthermore, it is contemplated that the method disclosed herein can be more generally applied to control vascular flow to and from any blood vessel, e.g., arteries and veins, during other minimally invasive surgical procedures including, but not limited to, laparoscopic, endoluminal, perivisceral, intra-articular and other endoscopic surgical procedures, as well as hybrid procedures. More specifically, the disclosed catheter can be targeted to a major blood vessel feeding into an operating site and its exact location is directly visualized using an endoscopic camera by illuminating the fiber and observing the light emitted in the vicinity of the balloon. Much as described for the example of the pulmonary artery in thoracoscopic surgery, in the event of an accidental injury during surgery, the balloon is rapidly inflated to prevent blood entry into the operative site, and thus provide a blood-free area in which to operate, or close a bleed.

In accordance with another aspect of the present invention, a catheter is sensed, moved, or anchored through the luminal wall, so that it passes or stops at particular positions in a blood vessel or passage defined by a magnet held outside the passage. The magnet, which may for example be carried on a wand, magnetically engages a magnetic pin, clip or collar located on the catheter. In the balloon embodiment, the magnetic wand may be positioned and moved endoscopically within a body cavity to engage the balloon and steer it past vessel branch points, or a magnet may be clipped in position to hold the balloon fixedly at one position and prevent the flowing blood from carrying the balloon along. The magnetic catheter may also be used for other types of catheter delivery systems, such as drug delivery, angioplasty or ablation catheters.

The advantages of the present invention include the direct visualization and control of the exact location of a catheter tip in vivo, without cumbersome radiographic procedures or expensive imaging equipment, thus allowing the rapid and dependable deployment of the catheter at a precise site to be ready if needed during surgery. Furthermore, the efficiency of pressure monitoring, blood sampling or drug infusion processes may be enhanced by allowing the placement of the catheter with greater precision and speed.

BRIEF DESCRIPTION OF THE DRAWINGS

These and other objects and advantages of the invention will be apparent from the specification and the drawings of illustrative embodiments, wherein:

FIG. 1 is a diagrammatic sectional view illustrating a flow-directed catheter of this invention positioned in the pulmonary artery;

FIG. 2 is a side elevational view of the catheter;

FIGS. 2A and 2B are enlarged side elevational views of the distal end of the catheter with the balloon in a deflated or inflated configuration, respectively;

FIG. 3 is an enlarged side sectional view of the distal end of the catheter when the balloon is inflated;

FIG. 4A is a schematic representation of direct emission regions of an optical fiber;

FIGS. 4B and 4C are enlarged side elevational views of the distal end with the catheter illuminated and the balloon inflated showing alternative positions of light emitting regions at the ends of the balloon (FIG. 4B) or along the balloon length (FIG. 4C);

FIGS. 5A and 5B are diagrams of different balloon shapes for a balloon catheter of the present invention;

FIG. 6 is a flow-chart illustrating the steps in the method of the invention; and

FIG. 7 shows a catheter of the present invention having a magnet for through-wall engagement.

DETAILED DESCRIPTION OF THE INVENTION

FIG. 1 illustrates a catheter 10 extending to the right side of a patient's heart H. In brief, the parts of the heart and their operation are as follows: the right atrium 12 receives blood from the superior and inferior vena cava 13 and 14, respectively, and pumps the received blood into the right ventricle 15 through the tricuspid valve 16. From the right ventricle, the blood travels through the pulmonary valve 17 and to the pulmonary artery 18 and on to the lungs. Oxygenated blood returning from the lungs enters the left atrium 19 and then passes through the mitral valve 20 into the left ventricle 21, which pumps blood out of the heart through the aortic valve 23 along the aorta 22. The pulmonary artery 18, while indicated as a single vessel, in fact branches close to the heart, with one passage going to the left lobe of the lungs and another going to the right lobe.

Catheter 10 is depicted in FIG. 2 as a flow-directed catheter having a thin, flexible, tubular body 11 and an inflatable balloon 26 attached to its distal end. The balloon is shown in a fully deflated and in a fully inflated condition (dashed lines) in FIGS. 2A and 2B, respectively. The diameter of the catheter varies depending on its desired use; however, the diameter is typically in the range of about 4 to 12 French (0.052 inch to 0.156 inch). Most preferably the catheter diameter is in the range of about 4 to 9 French. Exemplary catheter constructions are disclosed in U.S. Pat. Nos. 3,746,003, 3,833,004, 3,710,781, 3,634,924, 3,152,592, 3,044,468, 3,050,066 and 2,845,930, each of which is incorporated by reference herein.

For completeness, it is noted here that by "flow-directed", applicant means that the preferred balloon insertion process relies, at least in part, on the pressure of blood flow against the balloon to drive the balloon along, pulling the trailing catheter after it. Thus, unlike a relatively rigid angioplasty catheter that employs a deflated strong elastic balloon which is pushed along on a guide wire, or pushed by a stiff tube, the catheter contemplated by applicant employs a relatively soft and partly enlarged balloon, and a light, flexible catheter capable of bending freely to follow the balloon when blood flow propels the partially inflated balloon along a turning path through the heart.

Continuing with a description of FIG. 2, at its proximal end, the catheter body 11 terminates in a coupling 27, typically a short handle assembly, which operably connects the lumens of the catheter to connector tubes or lines 28, 29 and 30. All of these tubes or lines contain coupling elements 31-33 of appropriate type for attaching the connector lines to syringes, sampling instruments and other devices. In an illustrative embodiment, connector line 28 is operably attached through coupling element 31 to a balloon inflation unit 38 which pumps or injects fluid for rapid inflation or deflation of balloon 26; connector 29 is operably connected through a standard fiber optic coupler 32 to a light source 40; and optional connector tube 30 (shown in dashed lines) is attached via coupling element 33 such as a Luer connector to a monitor system 46 which for example includes instrumentation for at least one of pressure monitoring, blood sampling, and infusion of a therapeutic drug. Light source 40 may be any suitable light source. One such source may be a small battery-powered source having 5-10 W power consumption and emitting broadband visible light, such as a 6 W white light having an elliptical reflector configured to focus the light into a fiber for delivery via coupler 33. Another suitable source may be realized by coupling light from a standard 200 watt Xenon surgical endoscopic camera lighting unit. In this case, the standard source is preferably modified so that its output is partitioned between two optical ports, one for the endoscope and one for the catheter lights. In general a luminous flux of about 20-100 lumens is considered sufficient for the powering the fiber(s) of the catheter, representing approximately one to ten percent of the video illumination light. The partition may be readily achieved by a simple split-area Y-junction light guide or by other available optical hardware. The source ports may further be equipped with controls for dimming or blanking each output independently so that the illumination of the catheter can be viewed against a dimmed or unsaturated video image.

In accordance with a principal aspect of the present invention, the light provided to the balloon catheter is emitted at or near the balloon and serves as a visual aid to mark the location of the balloon at the catheter tip. For this reason, broadband white light is the preferred light for source 42. However, for application in minimally invasive surgery when an endoscopic video camera is used, the video camera may have a wavelength sensitivity greater than, or different than the human eye, and in that case in addition to white light, the invention may employ light of a specific wavelength, for example a wavelength to which the camera responds even if it would not be directly visible without detection by the camera. Further, the wavelength may be selected based on desirable characteristics, such as its ability to penetrate a vessel without absorption, or to provide a color contrast to the background tissue, or a similar property. It should be noted that in general a filter is provided to remove infrared (IR) light ahead of the camera to decrease the overall background noise. Thus, if an infrared wavelength is used to illuminate the beacon on the balloon it must be a narrow-band IR, preferably below one micrometer, and may be separated for detection, by a dichroic mirror or beam splitter, so that the rest of the image is not impaired. The light source may also be controlled to automatically dim or extinguish the general endoscope illumination when illuminating and viewing the balloon beacons, to enhance their visibility.

FIG. 3 shows an enlarged side sectional view of the distal end of the catheter body 11. Inflation lumen 40 is a passage extending through the catheter body 11 which communicates with connector tube 28 and conveys gas or another inflation medium to and from the balloon inflation unit 38 (FIG. 2). Inflation lumen 40 has a distal opening, or port 37 (FIGS. 2A, 2B) which may for example consist of a number of holes opening into the interior of balloon 26 for a fluid flow therethrough to rapidly inflate and deflate said balloon. Light fiber 42 is mounted in the inflation lumen or an adjacent lumen and extends longitudinally through said lumen (dashed lines). Fiber 42 carries light from light source 40 distally through the lumen to one or more emission regions such as the end face 42a, or regions 36, of which examples are shown in FIGS. 2A-B and 4B-C. In one embodiment, monitor lumen 44 operably connects to monitor system 46 via port 38 and connector tube 30. This lumen carries liquids, e.g., therapeutic drugs, blood, to or from the proximal and distal ends of the catheter. Syringes and other devices can be attached to monitor system 46 by methods known in the art.

At the distal end of catheter 10 in the vicinity of balloon 26, the fiber 42 forms or is coupled to one or more emitter regions 36 that emit light detectable through the walls of a blood vessel (FIGS. 4B and 4C). FIG. 4A depicts a thin optical fiber which has a core diameter ranging from 150 to 600 microns, most preferably in the range of about 300 to 500 microns. A high numerical aperture fiber is used to provide effective light transmission at a sufficient intensity to be remotely visible. The light source may include an IR filter to avoid applying excessive heat while nonetheless passing sufficient power to be readily visualized through the blood vessel without damaging the tissue therein. Light travels from light source 40 through the optical fiber to substantially entirely escape and project omnidirectionally at the light emitting regions 36 in the vicinity of the balloon (FIGS. 2 and 3). A light emitting region may be formed by fusing the end of the optical fiber to form a luminescent ball 34, FIG. 4A. Alternatively, or in addition, one or more light scattering regions 34A, 34B and 34C (FIGS. 4A-C) may be formed directly in the fiber by etching away the fiber cladding and roughening the surface of the fiber in local areas using an acid treatment or reactive etch methods known in the art or by coupling the fiber to a roughened transparent tube segment or the like. Alternative locations of the emitter regions 36 along the longitudinal axis of the catheter body 11 are contemplated in the present invention. The light emitting region can be positioned at the proximal end 34a, distal end 34b or the entire length 34c of the balloon 26 (FIGS. 4B and 4C). Any combination of these configurations is within the scope of the present invention. In addition, by placing different colored filters at the light emitting regions 34a-34c, an emitted pattern of light of different colors can provide a visible indication of precisely which part of the balloon is being viewed through the blood vessel wall. Several different light guides, for example a pair of 300 micron fibers, may be used to illuminate the different areas. Furthermore the light emitters may be positioned at radially outward positions, or extend as protrusions so that the optical path absorbance through blood to the outside is reduced, enhancing visibility. Preferably the fiber terminates and emits light precisely at the end of the catheter, from a non-projecting and atraumatic fiber end. Visibility of the light is greatly enhanced as the tip approaches the vessel wall.

The inflation openings 37 and monitor port 38a located at the distal end of catheter 10 operably connect the lumens of the catheter to the balloon interior and to the exterior vessel region, respectively (FIGS. 2, 2A and 2B). Port 37 is a lateral opening formed in the wall of the catheter body 11 to allow fluid flow therethrough for inflation and deflation of balloon 26. The monitor port 38a is located at the tip of the catheter body 11 distal to the balloon 26. When the catheter is properly positioned into the pulmonary capillary wedge position, port 38a may be used for measuring pulmonary artery or pulmonary capillary wedge pressure. Alternatively, port 38a may be used for injecting or infusing solutions, or for taking blood samples. The invention also contemplates an additional fluids port (not shown) located proximally of the balloon.

FIGS. 5A and 5B illustrate another embodiment of the present invention, wherein balloon 26 has plural segments or at least partially distinct body portions. These contain at least one portion which inflates to a size and shape capable of occluding, without necessarily distending, a blood vessel and a possibly different portion for stabilizing the balloon in position. In one configuration, inflated balloon 26 has two differently shaped portions consisting of a cylindrical shaped occlusion portion connected to a second separate portion that inflates to contact a blood vessel in at least two points (FIG. 5A) and anchor the assembly, but does not fully occlude the vessel lumen. The cylindrical inflated shape may more generally be a configuration where the largest diameter in a plane transverse to the long axis of the balloon is located intermediate the ends of the balloon, and the balloon diameter decreases in both directions toward the ends. This portion of the balloon inflates to a shape and size that occludes a blood vessel. The second portion anchors the balloon within the blood vessel by inflating to a cross-bar, a long curve, projecting fingers or a star-like shape, or other shape contacting the walls of the vessel sufficiently to anchor the assembly without fully occluding blood flow. In another configuration, the balloon has the above-described cylindrical inflated shape (FIG. 5B) but may, for example, be fabricated so it will curve longitudinally before expanding radially, or so that it otherwise wedges in position before occlusion, ready to fully inflate. The balloon size can be easily adapted for use in humans or non-human animals, e.g., pigs. The balloon may also be secured in place using any of the attachment methods known in the art, for example as shown in U.S. Pat. Nos. 3,995,623, 3,746,003 and 3,833,004. Mechanical anchoring devices, such as hooks or the like which are activated from the catheter handle, may be used to anchor the balloon in which case a single inflatable balloon, with a body shaped like that of a conventional Swan-Ganz catheter is used.

The inflation medium can be selected from any type of biocompatible fluid, preferably in gaseous form so that it pumps quickly through the catheter and has a fast response time, and preferably also being a material having rapid absorption in the blood, so as to reduce the possibility of injury in the event of balloon rupture. Carbon dioxide is a preferred inflation medium; however, other gases may be used under special circumstances.

Alternative methods of mechanically anchoring the balloon in a blood vessel are also envisioned in the present invention. These may include physically clamping the balloon by having a mechanically activated clamp or stent structure incorporated into the catheter end, or by surgically applying a partially constricting clamp or clip around the vessel in the surgical cavity to grip the balloon tip enough to prevent balloon migration along the vessel. Another method includes attaching a fragment or clip of magnetically-attractable material to the balloon, and then locking the balloon in place in a blood vessel using an external magnet. In that case the external magnet is manually positioned against the vessel wall to hold the balloon at a fixed site. The external magnet may, for example, be attached to the end of a rod or wand. In this embodiment the magnetic wand may also be used to steer the catheter to the correct pulmonary branch once it has passed through the right ventricle. Such a magnetically positioned catheter is shown in FIG. 7.

As shown in FIG. 7, a magnetically steerable catheter 100 according to this aspect of the invention includes a magnetically engageable element positioned at or near the catheter tip, preferably in a radially outer band so that it lies near to the vessel wall when the catheter is inserted endoluminally. FIG. 7 shows a ferrule or collar 110, which advantageously may clamp the end of balloon 26 to the catheter. Ferrule 110 may be formed of thin stock, e.g. about one-half millimeter thick and two to four millimeters wide, crimped about the tube. A magnetically susceptible material, e.g. a stainless steel such as a 400-series SS, may be used. Rather than a collar or clip, a pin or plug, such as a 1.5 to 3 millimeter diameter rod about 4-6 millimeters long, may be secured in the tip. The magnetic element may be inserted in a free catheter lumen, or encapsulated within the catheter body to assure that it doesn't detach. In this case non-surgical grade materials, such as soft iron or other magnetically suitable materials may be used. The mass of the element is preferably kept low so that neither its dimensions nor its inertial drag will prevent the catheter from sailing along, i.e., being flow-directed, in the blood stream, while its overall size is large enough to be strongly engaged by an external magnet.

As further shown in FIG. 7, a magnetic wand 200 is preferably provided to operate in conjunction with the magnetically positioned catheter 100. Wand 200 includes body portion 202, which as shown is an elongated handle or shaft, and a magnet 210 positioned at the end of the shaft. The body is comparable in shape to common endoscopic tools, such as scalpels, grippers and the like, having a generally rod-like shape under about five millimeters in diameter and a length of twenty or thirty centimeters. The magnetic element is a solid, high field strength permanent magnet, such as a samarium cobalt or rare-earth magnet, sized to also fit within the shaft envelope for introduction via a small trocar. When the magnet is held near the end of the catheter, strong field lines result in an attractive force between magnet 210 and the magnetically engageable catheter element 110, allowing the wand to engage, pull or hold the catheter through the vessel wall, at distances of up to several centimeters. When so engaged, the torque exerted on the wand handle via its elongated body 202 is readily felt by the operator, so the wand may be used to "feel" the position of the catheter tip by simply waving the wand or passing it along the vessel when the catheter is positioned therein.

In a preferred practice of the invention, the magnetic catheter system 100, 200 of the invention is used to endoscopically and remotely manipulate the catheter tip. Particularly useful steps involve sensing, by a magnetic "pull" on the wand, when the balloon tip is positioned near the heart, pulling the catheter tip back or around a branch point if it has sailed to the wrong branch (e.g., the right or left pulmonary artery), and anchoring the balloon tip at a desired position. As further shown in FIG. 7, the wand 200 may include a set of clips or pincers 205a, 205b which are remotely actuable through the handle to anchor the wand to nearby tissue. This allows the wand to hold the balloon at a fixed position. Such anchoring of the balloon has been found to be especially useful when the balloon is only partially inflated and thus prone to movement, when it is positioned in readiness for performing a hemostatic intervention, wedge pressure measurement or other catheter process, as described more fully below.

In another aspect, the present invention includes a surgical method for preventing or controlling hemorrhage in an enclosed surgical arena. FIG. 6 shows steps of this method. In an illustrative embodiment, a method is applied to obstruct vascular inflow to the pulmonary artery during minimally invasive thoracoscopic surgery. The method disclosed herein is preferably applied to pulmonary resections including, but not limited to, lobectomy, bilobectomy and pneumonectomy. In use, the soft, pliable catheter 10 having the balloon in a deflated configuration is inserted into a patient's median basilic or deep brachial vein by a cutdown, or it may be inserted percutaneously via the femoral, jugular or subclavian vein. Alternatively, the pulmonary artery may be accessed more directly from the chest. The catheter is then advanced by blood flow with or without fluoroscopic visualization into the right atrium 12 and right ventricle 15 and advanced to the branch of the pulmonary artery on the side of the lung which is to be operated on (FIG. 1). Prior to surgery, the balloon is moved to the exact location by illuminating its fiber and observing directly or through an endoscopic camera the light emitted in the pulmonary artery in the vicinity of balloon (FIGS. 4B and 4C). The catheter may be pulled back slightly and reinserted to the correct branch, or may be steered with a magnetic wand as described above, to the location, and the balloon is anchored in this position. In the event of accidental puncture of the pulmonary artery or a downstream blood vessel during surgery, the balloon is then rapidly inflated to occlude the pulmonary artery, thus stopping blood flow, and allowing the cut to be stapled or otherwise closed.

During the insertion process the magnetic wand may be employed to sense balloon position in a manner much like a divining rod, when the balloon resides in an opaque vessel or cardiac chamber. The wand is also effective to move the balloon and navigate it correctly through the valves or branch paints, and to anchor the balloon once its position is magnetically or visually confirmed. In order to effectively anchor the balloon, it is not necessary to employ the full structure of a wand. Rather, this aspect of the invention may be effected with a small magnet having a gripping structure, such as a barbed surface, that allows the magnet to fasten without sliding to the vessel and magnetically anchor the catheter. Such a magnetic pellet or clip may be delivered by a removable catch on the wand tip, or may be provided as a separate element to be delivered or manipulayed by a conventional endoscopic tool such as forceps. Furthermore, the anchoring function may be enhanced, in different embodiments, by providing magnetic elements similar to element 110 at different positions near the catheter tip but located longitudinally further from the balloon, thus allowing the magnet to approach the vessel wall more closely. For example a magnetic element 110 may be positioned at the very tip in the region denoted R1, positioned at the proximal balloon end as shown for band 110a, or positioned one or two centimeters proximal to the balloon in region R2, or otherwised spaced to allow the balloon to assume its occlusion or measurement position while placing the magnet in a location accessible to and anchorable by the wand 200. This magnet mechanism may also be used to navigate other catheters, such as angioplasty catheters and stent applicators, to desired treatment sites within vessels. When the band is located at the proximal balloon end or region R2 it may be substantially wider than the tip element 110 without impairing balloon delivery, thus providing a greater magnetic engagement force. In addition, providing several such magnetically-engageable elements provides greater static clamping forces, allows more flexibility in clamping the balloon near branches, buried vessels or obstructions, and increases the chances of effectively engaging and stopping the catheter as it is quickly carried along in the bloodstream.

In an experimental protocol using a prototype illuminated catheter, pulmonary artery blood flow has been interrupted intermittently in medium sized pigs using the catheter described in the present invention. The domestic pig was chosen as the experimental model because the porcine lung anatomy has well-defined lobar structure. Moreover, the pig has a defined distribution and branching of the pulmonary artery, the pulmonary veins and the bronchial system. The procedure was as follows. Briefly, a young adult pig (50-75 pounds) was anesthetized and airway intubated. Pulse rate, heart rhythm and blood pressure were monitored by conventional methods. Under fluoroscopic control the balloon catheter was flow directed into the branch of the pulmonary artery feeding into the surgical lung. A 3 cm-long cylindrical balloon was used. This balloon size has been tested to occlude, without overdistending, the porcine pulmonary artery. The animal was then placed in the thoracotomy position and the necessary thoracoscopic surgery port incisions, each approximately 2 cm in length, were created. An endoscopic camera and instruments were inserted. The proper location of the balloon was determined by viewing the light emitted in the vicinity of balloon, using the endoscopic camera. Inflation of the balloon interrupted blood flow into the operated lung allowing a blood-free area in which to perform lung surgery, e.g., pulmonary lobectomy, bilobectomy and pneumonectomy.

In another embodiment, this invention includes an improved method for monitoring blood pressure or sample infusion by directly determining the exact location of a catheter in vivo. With the catheter in the proper position, a variety of diagnostic procedures may take place, all of which are known in the art, and will only be described briefly here. For example, distal sampling port 38a may be used for measuring pulmonary artery and pulmonary wedge pressure by positioning the catheter into what is generally referred to as the pulmonary capillary wedge position. Monitor lumen 44 communicates with blood at the pulmonary arterial pressure when the catheter is in the wedge position and the balloon is deflated, or pulmonary capillary wedge position when the balloon is inflated. Pressure measurements are detected using monitor system 46. Alternatively, port 38a may be used for fluid sampling or injection of a therapeutic drug by attaching a syringe, containing such a fluid or drug, to the connector tube 30.

The invention has been described in the general context of hemostatic control during thoracic surgery. In accordance with a further feature of this aspect of the invention, the balloon may be selectively positioned to block one or the other lobe. To access the right main pulmonary artery, the marker- or beacon-modified Swan-Ganz catheter may be inflated in the out flow tract of the right ventricle, from which is carried directly to the right side. To access the left pulmonary artery and the left lung, the balloon is deflated in the out flow tract of the right ventricle, and then rapidly advanced to engage the left pulmonary artery and deflect to the left side, whereits position may be confirmed and the position adjusted as necessary by magnetic manipulation. Since the catheter has significant curvature or dead length, the magnet greatly facilitates any small motions that are necessary, such as retraction along the vessel, or moving to a position sufficiently away from the clipping or cutting sites. During surgery, the lung may be fully defunctioned by using a double lumen endotracheal tube or bronchus blocker. This gives a fully atalectactic shrunken lung in the large chest cavity, greatly facilitating visualization and operative manipulations in the surgical arena.

The invention may also be practiced during operations involving an open surgical arena. In that case the position of the balloon is determined by manipulation of the magnet and/or direct visual (non-endoscopic) observation of the light emission through tissue or a vessel in the operating site. In this case, the location of an endovascular balloon for hemostasis offers a flexible alternative for localized surgical blocking and emergency hemostasis. Furthermore, magnetically "feeling" the location of the catheter provides a fast, atraumatic indication of position. As further noted above, while the pulmonary artery is relatively transparent, the invention is expected to work equally well for other tubes, passages or vessels in laparoscopic and other applications.

Thus, although the invention has been extensively described with respect to a balloon-tipped catheter and a novel method of use to control hemorrhage during minimally invasive thorascocopic surgery, it is understood that the invention is applicable to all surgical procedures wherein an illuminated balloon catheter is viewed through the walls of a blood vessel or a magnetic catheter is felt and manipulated through the vessel, and to procedures wherein the catheter is used to occlude a vessel supplying the site of surgery. Furthermore, in its full generality, the method of locating a hemostatic balloon by directly sensing, e.g., feeling a magnetic pull or viewing a fiber-optic beacon, may be applied more generally to locate the distal tip of a catheter, even when no balloon is present. Thus, the invention contemplates positioning the tip of a drug delivery catheter, an ablation catheter, an endoluminal paving catheter, or other internally-positioned surgical device by constructing the catheter or other device with a light pipe or optical fiber to conduct light to one or more emitting beacons located to identify the active portion of the catheter, such as a drug delivery port, a stent delivery segment or a sampling inlet or biopsy cup, and then positioning the device in a passage by such illumination and trans-viewing. It also contemplates magnetic sensing and manipulation of the catheter end through the luminal wall. Various further modifications may be made to the invention described herein without departing from the intended scope of the invention, as set forth in the claims appended hereto.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US4063561 *Sep 20, 1976Dec 20, 1977The Signal Companies, Inc.Direction control device for endotracheal tube
US4384584 *Oct 28, 1981May 24, 1983Chen Allen SMethod and means for esophageal feeding
US4655746 *Dec 2, 1985Apr 7, 1987Target TherapeuticsCatheter device
US4671287 *Feb 3, 1986Jun 9, 1987Fiddian Green Richard GApparatus and method for sustaining vitality of organs of the gastrointestinal tract
US4777951 *Sep 19, 1986Oct 18, 1988Mansfield Scientific, Inc.Dilatation procedure
US4798588 *Mar 27, 1987Jan 17, 1989Rene AillonCentral venous pressure catheter and method for using
US4961738 *Dec 2, 1987Oct 9, 1990Mackin Robert AAngioplasty catheter with illumination and visualization within angioplasty balloon
US5007919 *Oct 11, 1989Apr 16, 1991Silva Fidel HMethod and apparatus for patient protection against vessel rupture from balloon-tipped catheters
US5019075 *Jul 31, 1990May 28, 1991The Beth Israel HospitalMethod and apparatus for angioplasty
US5324260 *Apr 27, 1992Jun 28, 1994Minnesota Mining And Manufacturing CompanyRetrograde coronary sinus catheter
US5370640 *Jul 1, 1993Dec 6, 1994Kolff; JackIntracorporeal catheter placement apparatus and method
US5395331 *Feb 23, 1993Mar 7, 1995Minnesota Mining And Manufacturing CompanyRetrograde coronary sinus catheter having a ribbed balloon
US5409483 *May 14, 1993Apr 25, 1995Jeffrey H. ReeseDirect visualization surgical probe
US5542938 *May 12, 1995Aug 6, 1996Cordis CorporationMagnetic guidewire coupling for catheter exchange
US5562657 *Sep 19, 1994Oct 8, 1996Griffin; Stephen E.Side fire laser catheter method and apparatus
US5700243 *May 24, 1996Dec 23, 1997Pdt Systems, Inc.Balloon perfusion catheter
US5722426 *Feb 26, 1996Mar 3, 1998Kolff; JackCoronary light probe and method of use
US5738652 *Jan 17, 1997Apr 14, 1998Heartport, Inc.Retrograde delivery catheter and method for inducing cardioplegic arrest
EP0283661A2 *Jan 25, 1988Sep 28, 1988Robert A. MackinAngioscope having a balloon with a recess
EP0363117A1 *Oct 2, 1989Apr 11, 1990Baxter International Inc.A position-monitoring flow-directed catheter and method
EP0422690A2 *Jan 9, 1987Apr 17, 1991Mountpelier Investments, S.A.Apparatus for selective monitoring/oxygenation of organs of the gastrointestinal tract
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US6081741 *May 19, 1999Jun 27, 2000Vector Medical, Inc.Infrared surgical site locating device and method
US6173199 *May 5, 1998Jan 9, 2001Syncro Medical Innovations, Inc.Method and apparatus for intubation of a patient
US6173715 *Mar 1, 1999Jan 16, 2001Lucent Medical Systems, Inc.Magnetic anatomical marker and method of use
US6219572 *Apr 22, 1999Apr 17, 2001Picker International, Inc.Imaging using a contrast agent
US6292678 *May 13, 1999Sep 18, 2001Stereotaxis, Inc.Method of magnetically navigating medical devices with magnetic fields and gradients, and medical devices adapted therefor
US6304769 *Oct 16, 1997Oct 16, 2001The Regents Of The University Of CaliforniaMagnetically directable remote guidance systems, and methods of use thereof
US6352543Apr 29, 2000Mar 5, 2002Ventrica, Inc.Methods for forming anastomoses using magnetic force
US6432136 *Apr 25, 2000Aug 13, 2002The Penn State Research FoundationApparatus and method for removing a pocket of air from a blood pump
US6454789 *Jan 15, 1999Sep 24, 2002Light Science CorporationPatient portable device for photodynamic therapy
US6511412 *Oct 16, 2000Jan 28, 2003L. Vad Technology, Inc.Cardivascular support control system
US6652540Aug 11, 2000Nov 25, 2003Ventrica, Inc.Methods for forming magnetic vascular anastomoses
US6699240 *Dec 12, 2001Mar 2, 2004Medtronic, Inc.Method and apparatus for tissue ablation
US6719768Aug 12, 2000Apr 13, 2004Ventrica, Inc.Magnetic components for use in forming anastomoses, creating ports in vessels and closing openings in tissue
US6802847Jul 23, 2001Oct 12, 2004Ventrica, Inc.Devices and methods for forming magnetic anastomoses and ports in vessels
US6834201May 5, 2003Dec 21, 2004Stereotaxis, Inc.Catheter navigation within an MR imaging device
US6895266Mar 26, 2001May 17, 2005Vector Medical Inc.Laser light emitter surgical site locating device and method
US6899723Jul 13, 2001May 31, 2005Light Sciences CorporationTranscutaneous photodynamic treatment of targeted cells
US6932827Mar 4, 2002Aug 23, 2005Medtronic, Inc.Methods and devices using magnetic force to form an anastomosis between hollow bodies
US6986782Aug 1, 2002Jan 17, 2006Light Sciences CorporationAmbulatory photodynamic therapy
US7166127Sep 24, 2004Jan 23, 2007Mitralign, Inc.Tissue fastening systems and methods utilizing magnetic guidance
US7232449Mar 12, 2003Jun 19, 2007Medtronic, Inc.Components, systems and methods for forming anastomoses using magnetism or other coupling means
US7241300May 23, 2003Jul 10, 2007Medtronic, Inc,Components, systems and methods for forming anastomoses using magnetism or other coupling means
US7273056Jun 19, 2002Sep 25, 2007The Trustees Of The University Of PennsylvaniaOptical guidance system for invasive catheter placement
US7314446Dec 3, 2004Jan 1, 2008Ep Medsystems, Inc.Method and apparatus for time gating of medical images
US7320786Dec 7, 2005Jan 22, 2008Light Sciences Oncology, Inc.Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes
US7329223 *May 31, 2001Feb 12, 2008Abbott Cardiovascular Systems Inc.Catheter with optical fiber sensor
US7431726Sep 24, 2004Oct 7, 2008Mitralign, Inc.Tissue fastening systems and methods utilizing magnetic guidance
US7468050Dec 24, 2003Dec 23, 2008L. Vad Technology, Inc.Long term ambulatory intra-aortic balloon pump
US7507205Apr 7, 2004Mar 24, 2009St. Jude Medical, Atrial Fibrillation Division, Inc.Steerable ultrasound catheter
US7585283Nov 16, 2004Sep 8, 2009Given Imaging Ltd.Device and method for examining a body lumen
US7637885 *Mar 29, 2005Dec 29, 2009Siemens AktiengesellschaftCatheter device for applying a medical cutting balloon intervention
US7648462Nov 29, 2004Jan 19, 2010St. Jude Medical, Atrial Fibrillation Division, Inc.Safety systems and methods for ensuring safe use of intra-cardiac ultrasound catheters
US7654958Apr 20, 2004Feb 2, 2010St. Jude Medical, Atrial Fibrillation Division, Inc.Method and apparatus for ultrasound imaging with autofrequency selection
US7691103Apr 28, 2007Apr 6, 2010Board Of Regents, The University Of Texas SystemDevices for use in transluminal and endoluminal surgery
US7713210Nov 23, 2004May 11, 2010St. Jude Medical, Atrial Fibrillation Division, Inc.Method and apparatus for localizing an ultrasound catheter
US7721742 *Mar 23, 2001May 25, 2010Johns Hopkins UniversityMethods for diagnostic and therapeutic interventions in the peritoneal cavity
US7757695Sep 7, 2007Jul 20, 2010The Trustees Of The University Of PennsylvaniaMethod for catheter placement
US7783338Jan 9, 2008Aug 24, 2010Advanced Cardiovascular Systems, Inc.Catheter with optical fiber sensor
US7792568Mar 17, 2003Sep 7, 2010Boston Scientific Scimed, Inc.MRI-visible medical devices
US7909837Sep 16, 2002Mar 22, 2011Medtronic, Inc.Methods, devices and systems for forming magnetic anastomoses
US7992573Oct 4, 2005Aug 9, 2011The Trustees Of The University Of PennsylvaniaOptically guided system for precise placement of a medical catheter in a patient
US7993361 *Mar 30, 2005Aug 9, 2011Siemens AktiengesellschaftDevice for removing a total vascular occlusion with OCT monitoring
US8021355 *Aug 12, 2005Sep 20, 2011Board Of Regents The University Of Texas SystemSystem, kit, and method of transgastric removal of visceral fat and other related methods
US8052607Apr 22, 2008Nov 8, 2011St. Jude Medical, Atrial Fibrillation Division, Inc.Ultrasound imaging catheter with pivoting head
US8057394Jun 30, 2007Nov 15, 2011St. Jude Medical, Atrial Fibrillation Division, Inc.Ultrasound image processing to render three-dimensional images from two-dimensional images
US8070684Dec 14, 2005Dec 6, 2011St. Jude Medical, Atrial Fibrillation Division, Inc.Method and system for evaluating valvular function
US8078261Dec 14, 2009Dec 13, 2011Children's Medical Center CorporationLight-guided transluminal catheter
US8109951 *Mar 30, 2005Feb 7, 2012Siemens AktiengesellschaftDevice for implementing a cutting balloon intervention with IVUS monitoring
US8142493Jul 22, 2008Mar 27, 2012Mitralign, Inc.Method of heart valve repair
US8187190Dec 14, 2006May 29, 2012St. Jude Medical, Atrial Fibrillation Division, Inc.Method and system for configuration of a pacemaker and for placement of pacemaker electrodes
US8241273Jan 11, 2010Aug 14, 2012Ncontact Surgical, Inc.Method and devices for coagulation of tissue
US8265732Dec 23, 2009Sep 11, 2012Corpak Medsystems, Inc.Catheter locator apparatus and method of use
US8317711Jun 16, 2007Nov 27, 2012St. Jude Medical, Atrial Fibrillation Division, Inc.Oscillating phased-array ultrasound imaging catheter system
US8332020Jan 28, 2011Dec 11, 2012Proteus Digital Health, Inc.Two-wrist data gathering system
US8382747Oct 18, 2007Feb 26, 2013Medtronic Cryocath LpMethod and apparatus for inflating and deflating balloon catheters
US8388680Oct 18, 2006Mar 5, 2013Guided Delivery Systems, Inc.Methods and devices for catheter advancement and delivery of substances therethrough
US8419638Nov 18, 2008Apr 16, 2013Proteus Digital Health, Inc.Body-associated fluid transport structure evaluation devices
US8460371Oct 21, 2003Jun 11, 2013Mitralign, Inc.Method and apparatus for performing catheter-based annuloplasty using local plications
US8465453 *Jun 5, 2006Jun 18, 2013Mayo Foundation For Medical Education And ResearchKits, apparatus and methods for magnetically coating medical devices with living cells
US8465479Jan 11, 2010Jun 18, 2013Ncontact Surgical, Inc.Method and devices for performing biatrial coagulation
US8480668Apr 6, 2010Jul 9, 2013Board Of Regents Of The University Of Texas SystemDevices for use in transluminal and endoluminal surgery
US8606347Aug 9, 2012Dec 10, 2013Corpak Medsystems, Inc.Catheter locator apparatus and method of use
US8622915Nov 7, 2011Jan 7, 2014St. Jude Medical, Atrial Fibrillation Division, Inc.Ultrasound image processing to render three-dimensional images from two-dimensional images
US8672863Jan 14, 2010Mar 18, 2014Given Imaging Ltd.Device and method for examining a body lumen
US8834361Nov 18, 2009Sep 16, 2014Cook Medical Technologies LlcSystems, devices and methods for accessing a bodily opening
US20090216066 *Apr 29, 2009Aug 27, 2009Bonutti Peter MMagnetically assisted medication delivery method
US20090326525 *May 6, 2009Dec 31, 2009Jessica HixonLaser fiber capillary apparatus and method
US20100191043 *Jan 26, 2010Jul 29, 2010Maquet Cardiovascular LlcMethods and devices for isolating a vessel
US20100261976 *Apr 6, 2010Oct 14, 2010Tyco Healthcare Group LpApparatus and System for Performing Surgery
US20110196187 *Feb 11, 2010Aug 11, 2011Abbott Cardiovascular Systems Inc.Magnetically sensitive drug carriers and delivery devices
CN100446723CJun 19, 2002Dec 31, 2008宾夕法尼亚大学理事会Optical guidance system for invasive catheter placement
EP1604243A2 *Mar 3, 2004Dec 14, 2005Philips Electronics N.V.Method and device for time-gated amplification of photons
WO1999062401A1 *Jun 4, 1999Dec 9, 1999Vector Medical IncInfrared surgical site locating device and method
WO2000069353A1 *May 11, 2000Nov 23, 2000Stereotaxis IncMethod of magnetically navigating medical devices with magnetic fields and gradients, and medical devices adapted therefor
WO2002064188A2 *Jan 3, 2002Aug 22, 2002Univ ArkansasInfrared assisted monitoring of a catheter
WO2002103409A2Jun 19, 2002Dec 27, 2002Univ PennsylvaniaOptical guidance system for invasive catheter placement
WO2003005877A2 *Jul 11, 2002Jan 23, 2003Given Imaging LtdDevice and method for examining a body lumen
WO2007145638A1 *Jun 16, 2006Dec 21, 2007Michael GertnerMedical devices with integral magnets and uses thereof
Classifications
U.S. Classification600/424, 606/2
International ClassificationA61M25/095, A61M25/01
Cooperative ClassificationA61M25/0108, A61M25/0125, A61M25/0127
European ClassificationA61M25/01C1, A61M25/01C8
Legal Events
DateCodeEventDescription
Oct 28, 2010FPAYFee payment
Year of fee payment: 12
Nov 3, 2006FPAYFee payment
Year of fee payment: 8
Nov 5, 2002FPAYFee payment
Year of fee payment: 4
Mar 6, 1998ASAssignment
Owner name: MASSACHUSETTS, UNIVERSITY OF, MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VANDER SALM, THOMAS J.;CONLAN, A. ALAN;REEL/FRAME:009026/0346
Effective date: 19980108
Owner name: SMITH & NEPHEW ENDOSCOPY, INC., MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KAZAKEVICH, YURI E.;EK, STEVEN W.;MIHALCA, GHEORGE;REEL/FRAME:009026/0348
Effective date: 19971230